Literature DB >> 21441812

Changes in immunohistochemical levels and subcellular localization after therapy and correlation and colocalization with CD68 suggest a pathogenetic role of Hsp60 in ulcerative colitis.

Giovanni Tomasello1, Vito Rodolico, Monica Zerilli, Anna Martorana, Fabio Bucchieri, Alessandro Pitruzzella, Antonella Marino Gammazza, Sabrina David, Francesca Rappa, Giovanni Zummo, Provvidenza Damiani, Salvatore Accomando, Manfredi Rizzo, Everly Conway de Macario, Alberto J L Macario, Francesco Cappello.   

Abstract

In an earlier work, the role of heat shock protein (Hsp60) in the pathogenesis of ulcerative colitis (UC) was suggested by its significant increase in the pathological mucosa parallel with an increase in inflammatory cells. More data in this direction are reported in this work. We analyzed by immunohistochemistry biopsies of colon tissue from 2 groups of patients with UC and treated with either 5-aminosalicylic acid (5-ASA) alone or in combination with a probiotic. We looked for inflammatory markers and Hsp60. Both the treatments were effective in reducing symptoms but the group treated with both 5-ASA and probiotics showed better clinical results. Amelioration of symptoms was associated with reduction of both inflammation and Hsp60, a reduction that was most marked in the group treated with 5-ASA and probiotics. The levels of Hsp60 positively correlated with those of CD68-positive cells, and double immunofluorescence showed a high index of colocalization of the chaperonin and CD68 in lamina propria. Immunoelectron microscopy showed that Hsp60-classically a mitochondrial protein-was abundantly also present in cytosol in biopsies taken at the time of diagnosis, but not after the treatment. Our data suggest that Hsp60 is an active player in pathogenesis of UC and it can be hypothesized that the chaperonin is responsible, at least in part, for initiation and maintenance of disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21441812     DOI: 10.1097/PAI.0b013e3182118e5f

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  13 in total

1.  Elevated blood Hsp60, its structural similarities and cross-reactivity with thyroid molecules, and its presence on the plasma membrane of oncocytes point to the chaperonin as an immunopathogenic factor in Hashimoto's thyroiditis.

Authors:  Antonella Marino Gammazza; Manfredi Rizzo; Roberto Citarrella; Francesca Rappa; Claudia Campanella; Fabio Bucchieri; Angelo Patti; Dragana Nikolic; Daniela Cabibi; Giandomenico Amico; Pier Giulio Conaldi; Pier Luigi San Biagio; Giuseppe Montalto; Felicia Farina; Giovanni Zummo; Everly Conway de Macario; Alberto J L Macario; Francesco Cappello
Journal:  Cell Stress Chaperones       Date:  2013-09-22       Impact factor: 3.667

Review 2.  Gut microbiota imbalance and chaperoning system malfunction are central to ulcerative colitis pathogenesis and can be counteracted with specifically designed probiotics: a working hypothesis.

Authors:  Maurizio Bellavia; Giovanni Tomasello; Marcello Romeo; Provvidenza Damiani; Attilio I Lo Monte; Luciano Lozio; Claudia Campanella; Antonella Marino Gammazza; Francesca Rappa; Giovanni Zummo; Massimo Cocchi; Everly Conway de Macario; Alberto J L Macario; Francesco Cappello
Journal:  Med Microbiol Immunol       Date:  2013-07-18       Impact factor: 3.402

Review 3.  Update on pathogenesis and predictors of response of therapeutic strategies used in inflammatory bowel disease.

Authors:  Emilio G Quetglas; Zlatan Mujagic; Simone Wigge; Daniel Keszthelyi; Sebastian Wachten; Ad Masclee; Walter Reinisch
Journal:  World J Gastroenterol       Date:  2015-11-28       Impact factor: 5.742

4.  Novel serum markers HSP60, CHI3L1, and IGFBP-2 in metastatic colorectal cancer.

Authors:  Michal Vocka; Daniel Langer; Vladimir Fryba; Jaromir Petrtyl; Tomas Hanus; Marta Kalousova; Tomas Zima; Lubos Petruzelka
Journal:  Oncol Lett       Date:  2019-09-26       Impact factor: 2.967

5.  Evidence for a role of autoantibodies to heat shock protein 60, 70, and 90 in patients with dermatitis herpetiformis.

Authors:  Michael Kasperkiewicz; Stefan Tukaj; Anna-Julia Gembicki; Pálma Silló; Anna Görög; Detlef Zillikens; Sarolta Kárpáti
Journal:  Cell Stress Chaperones       Date:  2014-03-19       Impact factor: 3.667

6.  Hsp10, Hsp70, and Hsp90 immunohistochemical levels change in ulcerative colitis after therapy.

Authors:  G Tomasello; C Sciumé; F Rappa; V Rodolico; M Zerilli; A Martorana; G Cicero; R De Luca; P Damiani; F M Accardo; M Romeo; F Farina; G Bonaventura; G Modica; G Zummo; E Conway de Macario; A J L Macario; F Cappello
Journal:  Eur J Histochem       Date:  2011-10-24       Impact factor: 3.188

7.  Probiotic supplementation promotes a reduction in T-cell activation, an increase in Th17 frequencies, and a recovery of intestinal epithelium integrity and mitochondrial morphology in ART-treated HIV-1-positive patients.

Authors:  Gabriella d'Ettorre; Giacomo Rossi; Carolina Scagnolari; Mauro Andreotti; Noemi Giustini; Sara Serafino; Ivan Schietroma; Giuseppe Corano Scheri; Saeid Najafi Fard; Vito Trinchieri; Paola Mastromarino; Carla Selvaggi; Silvia Scarpona; Gianfranco Fanello; Fausto Fiocca; Giancarlo Ceccarelli; Guido Antonelli; Jason M Brenchley; Vincenzo Vullo
Journal:  Immun Inflamm Dis       Date:  2017-04-20

Review 8.  Pharmacogenetics in inflammatory bowel disease: understanding treatment response and personalizing therapeutic strategies.

Authors:  Jesús K Yamamoto-Furusho
Journal:  Pharmgenomics Pers Med       Date:  2017-05-26

Review 9.  Toward Developing Chemical Modulators of Hsp60 as Potential Therapeutics.

Authors:  Qianli Meng; Bingbing X Li; Xiangshu Xiao
Journal:  Front Mol Biosci       Date:  2018-04-20

10.  Lipoma of the fossa femoralis mimicking a femoral hernia. Report of 2 cases.

Authors:  G Amato; G Romano; A Agrusa; V Rodolico; L Gordini; P G Calò
Journal:  Int J Surg Case Rep       Date:  2018-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.